JP2019515643A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019515643A5 JP2019515643A5 JP2018515676A JP2018515676A JP2019515643A5 JP 2019515643 A5 JP2019515643 A5 JP 2019515643A5 JP 2018515676 A JP2018515676 A JP 2018515676A JP 2018515676 A JP2018515676 A JP 2018515676A JP 2019515643 A5 JP2019515643 A5 JP 2019515643A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- cycloalkyl
- substituted
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021042947A JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222713P | 2015-09-23 | 2015-09-23 | |
| US62/222,713 | 2015-09-23 | ||
| PCT/US2016/053571 WO2017053886A2 (en) | 2015-09-23 | 2016-09-23 | Method of screening for agents for differentiating stem cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021042947A Division JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019515643A JP2019515643A (ja) | 2019-06-13 |
| JP2019515643A5 true JP2019515643A5 (enExample) | 2019-11-07 |
Family
ID=58387520
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515676A Pending JP2019515643A (ja) | 2015-09-23 | 2016-09-23 | 幹細胞分化剤のスクリーニング方法 |
| JP2021042947A Active JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021042947A Active JP7138207B2 (ja) | 2015-09-23 | 2021-01-08 | 幹細胞分化剤のスクリーニング方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11931347B2 (enExample) |
| EP (1) | EP3352566A4 (enExample) |
| JP (2) | JP2019515643A (enExample) |
| CN (2) | CN113527289A (enExample) |
| AU (2) | AU2016326718B2 (enExample) |
| CA (1) | CA2999503A1 (enExample) |
| IL (3) | IL258314B (enExample) |
| WO (1) | WO2017053886A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3352566A4 (en) | 2015-09-23 | 2019-07-31 | Minerva Biotechnologies Corporation | SCREENING METHOD FOR ACTIVE SUBSTANCES FOR DIFFERENTIATING STEM CELLS |
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| AU2018244449B2 (en) * | 2017-03-29 | 2024-07-11 | Minerva Biotechnologies Corporation | Agents for differentiating stem cells and treating cancer |
| CN107892690A (zh) * | 2017-11-30 | 2018-04-10 | 江苏杏睿生物科技有限公司 | Fascaplysin的衍生物及制备方法与用途 |
| WO2019126357A1 (en) * | 2017-12-19 | 2019-06-27 | Minerva Biotechnologies Corporation | Agents for treating cancer and methods for identifying said agents |
| CN107880040A (zh) * | 2017-12-22 | 2018-04-06 | 中国药科大学 | 一种四氢β－咔啉类衍生物及其制备方法与用途 |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| EP4171592A4 (en) | 2020-06-26 | 2024-07-31 | Minerva Biotechnologies Corporation | Methods for deriving dopaminergic neurons from pluripotent stem cells |
| CN116234828A (zh) * | 2020-07-29 | 2023-06-06 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| WO2022221415A2 (en) | 2021-04-13 | 2022-10-20 | The Regents Of The University Of California | Tetracyclic compounds for treating brain disorders |
| JP2025502615A (ja) | 2021-12-15 | 2025-01-28 | デリックス セラピューティクス，インク． | フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用 |
| CA3248038A1 (en) | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES |
| CN115521306B (zh) * | 2022-09-26 | 2024-03-26 | 贵州大学 | 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用 |
| CN115594675B (zh) * | 2022-11-02 | 2024-01-30 | 西安医学院 | 一种 β-卡巴林-肉桂酸骨架衍生物及制备方法和用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| US7625697B2 (en) | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| JPH11512294A (ja) * | 1995-09-01 | 1999-10-26 | ラモット ユニヴァーシティー オーソリティ フォア アップライド リサーチ アンド インダストリアル ディヴェロプメント リミテッド | 癌の治療、予防および発見を目的とする腫瘍細胞での蛋白ホスファターゼ２Ｃ−ＰＰ２Ｃα−発現の操作と検出 |
| ATE215950T1 (de) * | 1996-05-10 | 2002-04-15 | Icos Corp | Carbolinderivate |
| CN1774243A (zh) * | 2003-02-28 | 2006-05-17 | 霍华德弗洛里实验生理及医药学院 | 治疗组合物 |
| CN1852974A (zh) * | 2003-06-09 | 2006-10-25 | 密歇根大学董事会 | 用于治疗和诊断癌症的组合物和方法 |
| WO2004113300A1 (ja) * | 2003-06-23 | 2004-12-29 | Ono Pharmaceutical Co., Ltd. | 新規三環性複素環化合物 |
| BRPI0506977A (pt) * | 2004-01-23 | 2007-07-03 | Chiron Corp | composto de tetrahidrocarbolina como agentes anticáncer |
| US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
| US7601840B2 (en) * | 2004-03-15 | 2009-10-13 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the inhibition of angiogenesis |
| US20080064680A1 (en) * | 2004-09-14 | 2008-03-13 | Bamdad Cynthia C | Methods for Diagnosis and Treatment of Cancer |
| DK1875244T3 (en) * | 2005-03-30 | 2019-04-29 | Minerva Biotechnologies Corp | Proliferation of MUC1-Expressing Cells |
| WO2007076055A2 (en) * | 2005-12-22 | 2007-07-05 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| EA200970447A1 (ru) * | 2006-11-03 | 2009-10-30 | АйАрЭм ЭлЭлСи | Соединения и композиции в качестве ингибиторов протеинкиназы |
| US20090075926A1 (en) * | 2006-12-06 | 2009-03-19 | Bamdad Cynthia C | Method for identifying and manipulating cells |
| WO2009022104A1 (en) * | 2007-08-13 | 2009-02-19 | De Montfort University | Fascaplysin derivatives and their use in the treatment of cancer |
| EP2214485B1 (en) * | 2007-09-25 | 2016-07-20 | Minerva Biotechnologies Corp. | Methods for treatment of cancer |
| JP2011522515A (ja) * | 2008-04-10 | 2011-08-04 | マサチューセッツ インスティテュート オブ テクノロジー | 癌幹細胞を標的とする薬剤を同定する方法およびその使用 |
| WO2009140260A2 (en) * | 2008-05-13 | 2009-11-19 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Cancer stem cell immortalization |
| EP3228629A1 (en) | 2010-06-16 | 2017-10-11 | Minerva Biotechnologies Corporation | Reprogramming cancer cells |
| JP2012068225A (ja) * | 2010-08-25 | 2012-04-05 | Fujifilm Corp | 放射線画像撮影用グリッド及びその製造方法 |
| EP2561888A1 (en) * | 2011-08-23 | 2013-02-27 | Deutsches Krebsforschungszentrum | Protein comprising NC-1 for treating angiogenesis-related diseases |
| EP2768945B1 (en) * | 2011-10-17 | 2022-01-05 | Minerva Biotechnologies Corporation | Media for stem cell proliferation and induction |
| US20150224169A1 (en) * | 2012-09-06 | 2015-08-13 | Mcmaster University | Compounds and methods for selectively targeting cancer stem cells |
| KR20210082547A (ko) * | 2013-02-20 | 2021-07-05 | 미네르바 바이오테크놀로지 코포레이션 | Ｎｍｅ 저해제 및 ｎｍｅ 저해제의 사용 방법 |
| EP4233536B1 (en) * | 2013-08-12 | 2025-12-31 | Minerva Biotechnologies Corporation | TUMOR GROWTH STIMULATION METHOD |
| CN103880841B (zh) | 2014-02-20 | 2016-04-13 | 南通大学 | 含有β-咔啉-3-酰亚肼基的HDAC抑制剂及其制备方法和用途 |
| EP3352566A4 (en) | 2015-09-23 | 2019-07-31 | Minerva Biotechnologies Corporation | SCREENING METHOD FOR ACTIVE SUBSTANCES FOR DIFFERENTIATING STEM CELLS |
-
2016
- 2016-09-23 EP EP16849807.9A patent/EP3352566A4/en not_active Withdrawn
- 2016-09-23 JP JP2018515676A patent/JP2019515643A/ja active Pending
- 2016-09-23 AU AU2016326718A patent/AU2016326718B2/en active Active
- 2016-09-23 CA CA2999503A patent/CA2999503A1/en active Pending
- 2016-09-23 CN CN202110344230.XA patent/CN113527289A/zh active Pending
- 2016-09-23 CN CN201680064972.4A patent/CN108513537A/zh active Pending
- 2016-09-23 WO PCT/US2016/053571 patent/WO2017053886A2/en not_active Ceased
- 2016-09-23 US US15/762,897 patent/US11931347B2/en active Active
-
2018
- 2018-03-22 IL IL258314A patent/IL258314B/en unknown
-
2021
- 2021-01-04 IL IL279941A patent/IL279941B/en unknown
- 2021-01-08 JP JP2021042947A patent/JP7138207B2/ja active Active
- 2021-10-25 IL IL287558A patent/IL287558B2/en unknown
-
2022
- 2022-11-21 AU AU2022275400A patent/AU2022275400B2/en active Active
-
2024
- 2024-01-19 US US18/418,112 patent/US20240307359A1/en not_active Abandoned